EARNINGS AND TRADING: Corel loss widens; Christie sells Vennersys
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 9.85p on 02-01-2026 at 19:35:09 |
|---|---|
| Change | 0.00p 0% |
| Buy | 10.00p |
| Sell | 9.70p |
| Last Trade: | Buy 10,410.00 at 10.00p |
| Day's Volume: | 979,728 |
| Last Close: | 9.85p |
| Open: | 9.85p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.85p - 10.00p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £104.59m |
| VWAP: | 9.854071p |
| Shares in Issue: | 1.06b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 10,410 | 10.00p | Ordinary |
16:13:10 - 02-Jan-26 |
| Buy* | 40,444 | 9.9003p | Ordinary |
16:07:36 - 02-Jan-26 |
| Buy* | 10,000 | 10.00p | Ordinary |
16:05:29 - 02-Jan-26 |
| Unknown* | 500,000 | 9.75p | Ordinary |
15:59:40 - 02-Jan-26 |
| Buy* | 1 | 10.00p | Ordinary |
15:58:45 - 02-Jan-26 |
| Buy* | 4,368 | 9.9003p | Ordinary |
15:44:54 - 02-Jan-26 |
| Buy* | 417 | 9.8925p | Ordinary |
15:43:25 - 02-Jan-26 |
| Unknown* | 1,158 | 9.85p | Ordinary |
15:13:33 - 02-Jan-26 |
| Sell* | 1,000 | 9.7015p | Ordinary |
14:58:50 - 02-Jan-26 |
| Buy* | 1,925 | 10.00p | Ordinary |
14:56:02 - 02-Jan-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Jan 2026 11:06 am | RNS | Block listing 6 Monthly Return |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 2nd Jan 2026 7:00 am | RNS | Total Voting Rights |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 22nd Dec 2025 7:00 am | RNS | FDA approves extension for ACCRUFeR® |
| 18th Dec 2025 7:13 am | RNS | Block Listing Application |
| 11th Dec 2025 7:00 am | RNS-R | Shield Wins Gold at Titan Branding Awards |
| 3rd Dec 2025 7:04 am | RNS | Amends Senior Secured Debt Financing |
| 14th Nov 2025 7:03 am | RNS | Initiation of a Phase II Clinical Trial in Japan |
| 11th Nov 2025 7:00 am | RNS | ACCRUFeR Pediatric PK Results to be Presented |